Eli Lilly said Monday it will acquire Morphic Holding, a biotech developing a treatment for inflammatory bowel disease. Lilly will pay about $3.2 billion to buy the Waltham, Mass.-based company. That ...
SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Morphic Holding, Inc. (NASDAQ: MORF), any of its executive officers, or ...
AI tech developer and production studio Morphic is producing its first episodic anime series, “DQN,” from creator Kushagra Kushwaha, in partnership with Kushwaha’s Tokyo-based studio 4861.
Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced Monday, a transaction that includes an experimental medication for inflammatory ...
INDIANAPOLIS — Eli Lilly announced on Monday that they have reached an agreement to acquire the biopharmaceutical company Morphic. Morphic is a Massachusetts-based company that develops oral integrin ...
After more than doubling on Monday, Morphic Holding's (NASDAQ: MORF) shares are taking a beating on Tuesday. As of 11:10 a.m. EST, the biopharmaceutical company's stock is down by 13.6%. There are two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback